Exclusive Summary

• Backed by a US-FDA approved ANDA (ANDA213821 for 50/100mg strengths) which serves as a premier global quality endorsement, empowering rapid dossier adaptation and fast-track registration in emerging markets.
• Perfectly targets the rigid mass demand of over 537 million diabetic patients globally, exhibiting robust post-prandial blood sugar control that is highly essential for populations consuming high-carbohydrate diets.
• Maximizes China's mature API-to-FDF integrated supply chain to offer an FDA-standard product coupled with disruptive pricing, guaranteeing highly lucrative profit margins for distribution partners in tenders and private retail.